Page last updated: 2024-09-05

sb 203580 and Diabetes Mellitus

sb 203580 has been researched along with Diabetes Mellitus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inagaki, Y; Kido, J; Nagata, T; Nakajima, Y1
Feng, Y; Hu, X; Lei, W; Li, X; Lu, Y; Ma, X; Ma, Z; Wang, L; Zhang, Y1

Other Studies

2 other study(ies) available for sb 203580 and Diabetes Mellitus

ArticleYear
Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells.
    Oral diseases, 2015, Volume: 21, Issue:3

    Topics: Animals; Antibodies; Calgranulin A; Calgranulin B; Cells, Cultured; Dental Pulp; Diabetes Mellitus; Flavonoids; Gene Expression; Glycation End Products, Advanced; Imidazoles; Interleukin-1beta; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Pyridines; Rats; Receptor for Advanced Glycation End Products; RNA, Messenger

2015
Promotion of osteointegration under diabetic conditions by tantalum coating-based surface modification on 3-dimensional printed porous titanium implants.
    Colloids and surfaces. B, Biointerfaces, 2016, Dec-01, Volume: 148

    Topics: Animals; Apoptosis; Blotting, Western; Cell Adhesion; Cells, Cultured; Coated Materials, Biocompatible; Diabetes Mellitus; Imidazoles; Microscopy, Electron, Scanning; Osseointegration; Osteoblasts; p38 Mitogen-Activated Protein Kinases; Porosity; Printing, Three-Dimensional; Prostheses and Implants; Pyridines; Rabbits; Reactive Oxygen Species; Serum; Sheep; Surface Properties; Tantalum; Titanium

2016